Crohn Disease: all 1,923 studies

Page 7 of 20. Open to participants first (467), then studies with results posted, then the rest; newest registration first within each.

• Crohn Disease Exclusion Diet After Single Medication De-escalationCompletedNCT02472457Not applicableResults posted
• An ObserVatIonal STudy of the Effectiveness of AdaLimumab on Health and Disability Outcomes in New Zealand Patients With Immune-Mediated InflammaTorY Diseases (VITALITY)CompletedNCT02451839Results posted
• Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's DiseaseCompletedNCT02425111Phase 3Results posted
• Prevention of Recurrence of Crohn's Disease by Fecal Microbiota Therapy (FMT)TerminatedNCT02417974Phase 2Results posted
• Evaluate if Response to Infliximab or Adalimumab May be Regained With an ImmunomodulatorTerminatedNCT02413047Not applicableResults posted
• Safety and Efficacy of Andecaliximab in Participants With Moderately to Severely Active Crohn's DiseaseTerminatedNCT02405442Phase 2Results posted
• Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144TerminatedNCT02403323Phase 3Results posted
• A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's DiseaseCompletedNCT02394028Phase 3Results posted
• Corticosteroid Dosage for Crohn's Disease FlareTerminatedNCT02392286Phase 4Results posted
• Eating Behaviour in Crohn's DiseaseCompletedNCT02379117Results posted
• A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF TherapyCompletedNCT02365649Phase 2Results posted
• Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn's ColitisCompletedNCT02330653Phase 1/2Results posted
• To Evaluate the Safety and Efficacy of Remsima™ in Patients With Crohn's Disease (CD) or Ulcerative Colitis (UC)TerminatedNCT02326155Results posted
• Corticosteroids With Vedolizumab in Crohn's DiseaseTerminatedNCT02324699Phase 4Results posted
• Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease TherapeuticsCompletedNCT02316678Results posted
• One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's DiseaseTerminatedNCT02240121Phase 3Results posted
• One Year Study of Rifaximin Delayed Release (DR) in Crohn's DiseaseTerminatedNCT02240108Phase 3Results posted
• Trial of High Dose Vitamin D in Patient's With Crohn's DiseaseTerminatedNCT02208310Phase 4Results posted
• Oral Administration of AlequelTM for Patients With Inflammatory Bowel Disease (IBD)CompletedNCT02185183Phase 1/2Results posted
• Open Label Study to Evaluate Long Term Efficacy, Safety and Tolerability of Repeated Dosing in Subjects With Crohn's Disease and Who Participated and Successfully Completed M14-115CompletedNCT02185014Phase 3Results posted
• A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating MothersCompletedNCT02154425Phase 1Results posted
• Rapidity of Response to Adalimumab Treatment in Patients With Crohn´s DiseaseCompletedNCT02148718Phase 4Results posted
• Fecal Microbiota Transplantation in Pediatric PatientsCompletedNCT02108821Phase 1Results posted
• Demonstrate Noninferiority in Efficacy and to Assess Safety of CT-P13 in Patients With Active Crohn's DiseaseCompletedNCT02096861Phase 3Results posted
• Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects With Moderate to Severe Crohn's DiseaseCompletedNCT02065570Phase 3Results posted
• A Phase 1/2 Study of Repeated Intravenous E6011 Administration in Japanese Subjects With Crohn's DiseaseCompletedNCT02039063Phase 1/2Results posted
• Phase III Study of MLN0002 (300 mg) in Treatment of Crohn's DiseaseCompletedNCT02038920Phase 3Results posted
• Efficacy, Safety and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Patients With Active, Moderate-to-severe Crohn's Disease.CompletedNCT02031276Phase 2Results posted
• A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the PlacentaCompletedNCT02019602Phase 1Results posted
• Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Two Treatment Modules in Chinese Subjects With Moderate to Severe Crohn's DiseaseCompletedNCT02015793Phase 2Results posted
• Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease With Ferrous SulphateCompletedNCT01991314Phase 4Results posted
• A Study of Adalimumab After Dose Escalation in Japanese Subjects With Crohn's DiseaseCompletedNCT01958827Phase 3Results posted
• Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's DiseaseCompletedNCT01951326Phase 3Results posted
• Monitoring Disease Activity Using Video Capsule Endoscopy (VCE) in Crohn's Disease (CD) SubjectsCompletedNCT01942720Not applicableResults posted
• Anti-Tumor Necrosis Factor (TNF) Treatments, Work Productivity and Quality of Life in Crohn's DiseaseCompletedNCT01860846Results posted
• Web-based Monitoring in Children and Adolescents With Inflammatory Bowel DiseaseCompletedNCT01860651Not applicableResults posted
• A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)CompletedNCT01804166Phase 4Results posted
• Comparison of Capso Vision SV-1 to PillCam SB2 in the Evaluation of Subjects With Suspected Small Bowel DiseaseCompletedNCT01787825Not applicableResults posted
• Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical PracticeCompletedNCT01768858Results posted
• An Observational Study of Fecal Calprotectin as Clinical Tool in Monitoring Moderate-to-severe Crohn's Disease on Adalimumab Induction Therapy: a KoRean Experience (FAIR)CompletedNCT01759264Results posted
• Bacteriotherapy in Pediatric Inflammatory Bowel DiseaseCompletedNCT01757964Phase 1Results posted
• Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.CompletedNCT01714726Phase 2Results posted
• Cimzia Versus Mesalamine for Crohn's RecurrenceTerminatedNCT01696942Phase 4Results posted
• Abrilumab (AMG 181) in Adults With Moderate to Severe Crohn's DiseaseCompletedNCT01696396Phase 2Results posted
• Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)CompletedNCT01692743Phase 3Results posted
• PillCam® Platform With the PillCam Crohn's Disease CapsuleCompletedNCT01631435Phase 1/2Results posted
• Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to PlaceboCompletedNCT01576471Phase 2Results posted
• Evaluation of a PillCam Colon Bowel Preparation Regimen in Crohn's Disease PatientsCompletedNCT01576120Phase 1/2Results posted
• Crohn's Allogeneic Transplant StudyTerminatedNCT01570348Phase 2Results posted
• Perfusion Assessment in Laparoscopic Left Anterior ResectionCompletedNCT01560377Phase 1Results posted
• Dose Ranging Study of BMS-945429 in Subjects With Moderate to Severe Crohn's DiseaseTerminatedNCT01545050Phase 2Results posted
• An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's DiseaseTerminatedNCT01536418Phase 3Results posted
• Phase III Study of D9421-C 9 mg in Patients With Active Crohn's Disease in JapanCompletedNCT01514240Phase 3Results posted
• A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's DiseaseCompletedNCT01470599Phase 2Results posted
• Special Investigation (Long-term Investigation) in Patients With Crohn's DiseaseCompletedNCT01464333Results posted
• Safety and Maintenance Study of Entocort for Children With Crohn's DiseaseCompletedNCT01453946Phase 3Results posted
• Safety Study of Entocort for Children With Crohn's DiseaseCompletedNCT01444092Phase 3Results posted
• A Safety and Efficacy Study of BLI-1300 Ointment in Symptomatic Perianal Crohn's DiseaseTerminatedNCT01442363Phase 2Results posted
• Understanding the Relationship Between Infliximab Levels to Clinical Response of Remicade in Crohn's DiseaseTerminatedNCT01438151Not applicableResults posted
• Safety and Tolerability of Single Doses Oral CNDO 201 Trichuris Suis Ova in Patients With Crohn's DiseaseCompletedNCT01434693Phase 1Results posted
• Reveal the Level of Anxiety in Patients With Crohn's Disease Receiving AdalimumabCompletedNCT01428115Results posted
• The Safety And Efficacy Of Maintenance Therapy With CP-690,550CompletedNCT01393899Phase 2Results posted
• A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's DiseaseCompletedNCT01393626Phase 2Results posted
• Evaluate PF-00547659 On Cerebrospinal Fluid Lymphocytes In Volunteers With Crohn's Disease Or Ulcerative Colitis Who Failed Or Did Not Tolerate Anti-TNFsCompletedNCT01387594Phase 1Results posted
• A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI)CompletedNCT01369355Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2)CompletedNCT01369342Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)CompletedNCT01369329Phase 3Results posted
• Anal Human Papillomavirus in Inflammatory Bowel Disease StudyCompletedNCT01364896Results posted
• Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Crohn's Disease (AEGIS-2)CompletedNCT01352221Phase 3Results posted
• Biomarkers of Intestinal Mucosal Healing in Crohn's Disease (P08143)CompletedNCT01349920Results posted
• B0151005 Open-Label Extension StudyCompletedNCT01345318Phase 2Results posted
• Open-Label Extension Study of GSK1605786ATerminatedNCT01318993Phase 3Results posted
• GSK1605786A in the Maintenance of Remission in Subjects With Crohn's DiseaseTerminatedNCT01316939Phase 3Results posted
• Special Investigation in Patients With Crohn's Disease (All Patients Investigation)CompletedNCT01298648Results posted
• A Study To Monitor Long-Term Treatment With PF-00547659CompletedNCT01298492Phase 2Results posted
• Telemedicine To Provide Inflammatory Bowel Disease Outpatient CareCompletedNCT01296841Phase 2Results posted
• Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Refractory Crohn's DiseaseTerminatedNCT01288053Phase 1/2Results posted
• A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF TherapyCompletedNCT01287897Phase 2Results posted
• A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's DiseaseCompletedNCT01277666Phase 3Results posted
• Intra-erythrocyte Dexamethasone Versus Placebo in Patients With Steroid-dependent Crohn's DiseaseTerminatedNCT01277289Phase 3Results posted
• Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's DiseaseCompletedNCT01276509Phase 2Results posted
• Efficacy and Safety of Two Treatment Algorithms in Adults With Moderate to Severe Crohn's DiseaseCompletedNCT01235689Phase 3Results posted
• Study of Vedolizumab in Patients With Moderate to Severe Crohn's DiseaseCompletedNCT01224171Phase 3Results posted
• Long-term Safety Study of Brodalumab in Adults With Crohn's DiseaseTerminatedNCT01199302Phase 2Results posted
• A Multicenter Trial Comparing REMICADE (Infliximab) and Placebo in the Prevention of Recurrence in Crohn's Disease (CD) Patients Undergoing Surgical Resection Who Are at an Increased Risk of RecurrenceTerminatedNCT01190839Phase 3Results posted
• Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab PegolCompletedNCT01190410Phase 2Results posted
• PDA001 for the Treatment of Adults With Moderate-to-Severe Crohn's DiseaseCompletedNCT01155362Phase 2Results posted
• Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn's DiseaseTerminatedNCT01150890Phase 2Results posted
• Inositol in Preventing Colorectal Cancer in Patients With Colitis-Associated DysplasiaTerminatedNCT01111292Phase 1/2Results posted
• Advanced Metagenomic Analysis of Human Colonic Microbiota in Patients With Chronic GI DisordersCompletedNCT01099111Results posted
• Effectiveness and Safety in Patients With Crohn´s Disease in Clinical RoutineCompletedNCT01083680Results posted
• Surveillance of Humira Injection in Korean PatientsCompletedNCT01083121Results posted
• Remission in Subjects With Crohn's Disease, Open Label ExtensionCompletedNCT01070303Phase 3Results posted
• An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's DiseaseTerminatedNCT01009281Phase 2Results posted
• A Dose-finding and Confirmatory Trial of OPC-6535 in Patients With Active Crohn's DiseaseCompletedNCT00989573Phase 2/3Results posted
• An Audit of Patients With Crohn's Disease Treated With Infliximab (P06066)CompletedNCT00988832Results posted
• Dietetic Efficacy of Mare's Milk for Patients With Chronic Inflammatory Bowel DiseasesCompletedNCT00940576Not applicableResults posted
• NIH Substudy of AIN457 (Anti-IL-17 Monoclonal Antibody) for Treatment of Moderate to Severe Crohn's DiseaseTerminatedNCT00936585Not applicableResults posted
• The Use of Certolizumab Pegol for Treatment of Active Crohn's Disease in Children and AdolescentsTerminatedNCT00899678Phase 2Results posted
• A Study With Pentasa in Patients With Active Crohn's DiseaseTerminatedNCT00862121Phase 3Results posted

← Crohn Disease overview